Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has...
Leadership
Ryan H. Saadi M.D., M.P.H.Founder
Co-Founder, CEO & Chairperson
Kirti Desai CPA
Chief Financial Officer
Neal Flomenberg M.D.
Chief Scientific Officer and Global R&D Lead
Stephen Chen M.B.A.
Chief Technical Officer
Mittul Mehta
Chief Information Officer & Head of Tevogen.ai
Tapan V. Shah
Head of Investor Relations & Corporate Development
Sadiq Khan M.B.A.
Chief Commercial Officer & Interim Head of Tevogen Generics
David E. Banko CPA
Global Head of Government Affairs & Patient Access
